ARRY
Price
$6.09
Change
+$0.46 (+8.17%)
Updated
Dec 23, 04:59 PM (EDT)
78 days until earnings call
BBIO
Price
$27.74
Change
+$1.25 (+4.72%)
Updated
Dec 23, 04:59 PM (EDT)
59 days until earnings call
Ad is loading...

ARRY vs BBIO

Header iconARRY vs BBIO Comparison
Open Charts ARRY vs BBIOBanner chart's image
Array Technologies
Price$6.09
Change+$0.46 (+8.17%)
Volume$191.6K
CapitalizationN/A
BridgeBio Pharma
Price$27.74
Change+$1.25 (+4.72%)
Volume$30.53K
CapitalizationN/A
ARRY vs BBIO Comparison Chart
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. BBIO commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Hold and BBIO is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (BBIO: $26.49)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green while.

  • BBIO’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 4 TA indicator(s) are bullish while BBIO’s TA Score has 6 bullish TA indicator(s).

  • ARRY’s TA Score: 4 bullish, 5 bearish.
  • BBIO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BBIO is a better buy in the short-term than ARRY.

Price Growth

BBIO (@Biotechnology) experienced а -3.64% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.79%. For the same industry, the average monthly price growth was -2.59%, and the average quarterly price growth was +3.59%.

Reported Earning Dates

BBIO is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-1.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBIO($5.25B) has a higher market cap than ARRY($2.22B). BBIO YTD gains are higher at: -34.382 vs. ARRY (-66.488). ARRY has higher annual earnings (EBITDA): 276M vs. BBIO (-350.26M). BBIO has more cash in the bank: 266M vs. ARRY (249M). ARRY has less debt than BBIO: ARRY (730M) vs BBIO (1.73B). ARRY has higher revenues than BBIO: ARRY (1.58B) vs BBIO (218M).
ARRYBBIOARRY / BBIO
Capitalization2.22B5.25B42%
EBITDA276M-350.26M-79%
Gain YTD-66.488-34.382193%
P/E Ratio26.23N/A-
Revenue1.58B218M723%
Total Cash249M266M94%
Total Debt730M1.73B42%
FUNDAMENTALS RATINGS
ARRY: Fundamental Ratings
ARRY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
30
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARRYBBIO
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 29 days ago
81%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 5 days ago
76%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 7 days ago
78%
View a ticker or compare two or three
Ad is loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEGRX168.181.46
+0.88%
MFS Growth R2
SRVEX21.950.18
+0.83%
Victory Diversified Stock A
JHTAX19.400.14
+0.73%
JPMorgan Hedged Equity 3 A
FARLX13.210.09
+0.69%
FS Chiron Real Development A
NRIQX12.530.01
+0.08%
Neuberger Berman International Eq R6

ARRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARRY has been closely correlated with SHLS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARRY jumps, then SHLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRY
1D Price
Change %
ARRY100%
+5.43%
SHLS - ARRY
66%
Closely correlated
+12.78%
FSLR - ARRY
61%
Loosely correlated
+3.70%
NXT - ARRY
59%
Loosely correlated
+3.87%
RUN - ARRY
57%
Loosely correlated
+8.11%
AXON - ARRY
53%
Loosely correlated
+2.60%
More

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ARGX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
+1.07%
ARGX - BBIO
46%
Loosely correlated
-0.35%
AXON - BBIO
44%
Loosely correlated
+2.60%
ARRY - BBIO
43%
Loosely correlated
+5.43%
BPMC - BBIO
43%
Loosely correlated
+1.36%
PMN - BBIO
43%
Loosely correlated
+1.88%
More